doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: k-dur

1 - 5 of 8 <<previous | next>>

Drugs results:

Perindopril tablets

Perindopril

Perindopril is in a class of drugs called angiotensin-converting-enzyme inhibitors (ACE inhibitors). Indications : essential hypertension (to lower high blood pressure), congestive heart failure or CHF ( to decrease the heart’s workload), prevention of st more...

K-Dur tablets

K-Dur

K-Dur, sometimes called Potassium Chloride, is used to supplement Potassium that is needed to maintain good health. Although a balanced diet usually supplies all the potassium a person needs, K-Dur is used by patients who do not have enough potassium in more...

Ramipril capsule

Ramipril

Ramipril is in a class of drugs called angiotensin-converting-enzyme inhibitors (ACE inhibitors). The common ending of these drugs is – PRIL . Indications: Treatment of hypertension (high blood pressure), alone or in combination with thiazide diuretic more...

Potassium Chloride tablets

Potassium Chloride

Sometimes called K-Dur, Potassium Chloride is used to supplement Potassium that is needed to maintain good health. Although a balanced diet usually supplies all the potassium a person needs, Potassium Chloride is used by patients who do not have enough po more...

Irbesartan tablets

Irbesartan

Irbesartan is in a class of drugs called angiotensin II receptor antagonists. Irbesartan prevents the constriction (narrowing) of blood vessels (veins and arteries) also termed as vasodilator agents. more...

Diseases results:

High blood pressure
Digestive system
Irregular heartbeat
Supplement

Articles results:

Agreements To Delay Market Entry Of Generic Prescription Drugs Increase
The St. Louis Post-Dispatch on Sunday examined the recent increase in the number of agreements in which brand-name pharmaceutical companies pay generic pharmaceutical companies to delay market entry of their products (Feldstein, St. Louis Post-Dispatch, 10/29). The


Schering-Plough To Pay $435M To Settle Allegations Of Improper Marketing
Schering-Plough on Wednesday was sentenced to pay $435 million as part of a settlement with the Department of Justice over accusations that the company improperly marketed prescription drugs for "off-label" use and lied to the government about drug prices, the Washington Post reports (Washington Post, 1/18).


FTC Asks Lawmakers To Ban Agreements To Delay Market Entry Of Generic Medications
The Federal Trade Commission on Wednesday at a hearing of the Senate Judiciary Committee asked lawmakers to take action to prevent agreements in which brand-name pharmaceutical companies pay generic pharmaceutical companies to delay market entry of their products, the




1 - 5 of 8 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.